Daily non-political popular news in brief.

COX inhibitors may weaken protective qualities of estrogen hormone therapy

Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy.

Read more »

Keywords: cox, inhibitors, weaken, protective, qualities, estrogen, hormone, therapy, inhibitor, quality

« Previous | Next »

Similar news on "COX inhibitors may weaken protective qualities of estrogen hormone therapy":

1. Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
   03-01-2007 · EurekAlert!
   Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.
   Similar news · Read more »
   
2. New biomarker predicts effectiveness of breast cancer drugs
   12-07-2006 · EurekAlert!
   University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
   Similar news · Read more »
   
3. Estrogen use before 65 linked to reduced risk of Alzheimer's disease
   05-02-2007 · EurekAlert!
   Women who use hormone therapy before the age of 65 could cut their risk of developing Alzheimer's disease or dementia. This possibility is raised by research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28-May 5, 2007.
   Similar news · Read more »
   
4. UW study to clarify safety, effectiveness of hormone therapy during menopause
   05-22-2007 · EurekAlert!
   When is the best time in a woman's reproductive history to start hormone therapy? How does estrogen therapy affect a woman's cognition and mood? What is the most beneficial form of estrogen?
   Similar news · Read more »
   
5. COX-2 inhibitors delay pancreatic cancer precursors in mice
   08-01-2007 · EurekAlert!
   Nimesulide, a cyclooxygenase-2 inhibitor, delays the progression of precancerous pancreatic lesions in mice, according to an article in the Aug. 1 issue of the journal Cancer Research.
   Similar news · Read more »
   
6. Hormone drug type makes survival difference in advanced breast cancer
   01-30-2007 · EurekAlert!
   Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.
   Similar news · Read more »
   
7. Hormone therapy offers new hope for ovarian cancer patients
   06-14-2007 · EurekAlert!
   Researchers have shown that the use of anti-estrogen drugs can extend life in ovarian cancer patients by up to three years.
   Similar news · Read more »
   
8. Hormone therapy does not improve quality of life for women
   11-06-2006 · EurekAlert!
   A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women's quality of life. The group receiving hormones and the comparison group showed no differences in general quality of life. Only those women that experienced hot flashes and night-time sweating reported beneficial effects.
   Similar news · Read more »
   
9. Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
   10-23-2006 · EurekAlert!
   While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
   Similar news · Read more »
   
10. Estrogen therapy in younger postmenopausal women linked to less plaque in arteries
    06-20-2007 · EurekAlert!
    New results from a substudy of the Women's Health Initiative (WHI) Estrogen-Alone Trial show that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less buildup of calcium plaque in their arteries compared to their peers who did not take hormone therapy.
    Similar news · Read more »